Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

Share Price is delayed by 15 minutes
Get Live Data
550.80    20.80 (3.92%)
Bid:
551.00
Ask:
551.80
Spread: 0.80 (0.145%)
Market Cap: £3.52b
ENT Live PriceLast checked at - London Stock Exchange

Intraday Entain Share Chart

Form 8.3 - Entain plc

12 Oct 2021 07:26

RNS Number : 7751O
Societe Generale SA
12 October 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Société Générale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Entain plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11/10/2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES: DraftKings Inc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

9,957,173

1.70

72,269

0.01

(2) Cash-settled derivatives:

 

0

0.00

943,649

0.16

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

9,957,173

1.70

1,015,918

0.17

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit GBP

Ordinary

Purchase

399

21.08

Ordinary

Purchase

7,852

21.08

Ordinary

Purchase

4,623

21.08

Ordinary

Purchase

23,576

21.08

Ordinary

Purchase

7

21.08

Ordinary

Purchase

214

21.08

Ordinary

Purchase

9

21.08

Ordinary

Purchase

214

21.08

Ordinary

Purchase

214

21.08

Ordinary

Purchase

214

21.08

Ordinary

Purchase

1,964

21.08

Ordinary

Purchase

1,981

21.08

Ordinary

Purchase

203

21.08

Ordinary

Purchase

2,480

21.08

Ordinary

Purchase

214

21.08

Ordinary

Purchase

214

21.08

Ordinary

Purchase

2,332

21.08

Ordinary

Sale

32

21.06

Ordinary

Sale

8

21.06

Ordinary

Sale

76

21.06

Ordinary

Sale

13

21.06

Ordinary

Sale

45

21.06

Ordinary

Sale

76

21.06

Ordinary

Sale

214

21.06

Ordinary

Sale

108

21.06

Ordinary

Sale

1

21.06

Ordinary

Sale

38

21.06

Ordinary

Sale

41

21.06

Ordinary

Sale

8

21.06

Ordinary

Sale

99

21.06

Ordinary

Sale

97

21.06

Ordinary

Sale

82

20.93

Ordinary

Sale

169

20.93

Ordinary

Sale

249

20.93

Ordinary

Sale

100

21.17

Ordinary

Sale

70

21.17

Ordinary

Sale

3

21.03

Ordinary

Sale

124

21.03

Ordinary

Sale

148

21.33

Ordinary

Sale

2,332

21.08

Ordinary

Sale

2,480

21.08

Ordinary

Sale

243

21.05

Ordinary

Sale

85

21.01

Ordinary

Sale

125

21.01

Ordinary

Sale

125

21.12

Ordinary

Sale

86

21.13

Ordinary

Sale

4

21.12

Ordinary

Sale

25

21.14

Ordinary

Sale

131

21.15

Ordinary

Sale

1,435

21.15

Ordinary

Sale

369

21.15

Ordinary

Sale

286

20.97

Ordinary

Sale

210

21.11

Ordinary

Sale

146

21.11

Ordinary

Sale

210

21.11

Ordinary

Sale

441

21.11

Ordinary

Sale

100

21.02

Ordinary

Sale

2

21.02

Ordinary

Sale

64

21.02

Ordinary

Sale

206

21.15

Ordinary

Sale

33

21.15

Ordinary

Sale

238

21.01

Ordinary

Sale

100

21.06

Ordinary

Sale

175

21.17

Ordinary

Sale

75

21.17

Ordinary

Sale

100

21.17

Ordinary

Sale

253

21.01

Ordinary

Sale

147

21.03

Ordinary

Sale

100

21.14

Ordinary

Sale

140

21.13

Ordinary

Sale

136

21.05

Ordinary

Sale

10

21.06

Ordinary

Sale

162

21.17

Ordinary

Sale

100

21.17

Ordinary

Sale

32

21.01

Ordinary

Sale

100

21.01

Ordinary

Sale

117

21.06

Ordinary

Sale

100

21.17

Ordinary

Sale

100

21.17

Ordinary

Sale

130

21.11

Ordinary

Sale

58

21.17

Ordinary

Sale

100

21.17

Ordinary

Sale

76

21.03

Ordinary

Sale

110

21.03

Ordinary

Sale

186

21.03

Ordinary

Sale

877

21.11

Ordinary

Sale

223

21.02

Total Purchases

46,710

Total Sales

14,884

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

GBP

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit GBP

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) GBP

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

12/10/2021

Contact name:

Paul Jenkins

Telephone number*:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETMTBFTMTTBMAB
Date   Source Headline
3rd Mar 20257:00 amRNSTotal Voting Rights
14th Feb 20251:52 pmRNSDirectorate and Board Committee Changes
14th Feb 202510:49 amRNSTR1: Notification of Major Holdings
11th Feb 20257:00 amRNSDirectorate Change
4th Feb 202512:00 pmRNSBETMGM FY 2024 Update
31st Jan 20257:00 amRNSTR1: Notification of Major Holdings
13th Jan 20257:00 amRNSReiteration of FY24 EBITDA guidance
6th Jan 20259:06 amRNSDirector/PDMR Shareholding
3rd Jan 202512:04 pmRNSBlock Listing Six Monthly Return
2nd Jan 20257:50 amRNSTotal Voting Rights
17th Dec 20247:00 amRNSBlock Listing Application
16th Dec 20247:00 amRNSAcknowledgement of AUSTRAC Proceedings
13th Dec 202410:39 amRNSBoard Committee Change
5th Dec 202412:20 pmRNSDirector/PDMR Shareholding
2nd Dec 20247:00 amRNSTotal Voting Rights
29th Nov 20247:00 amRNSTR1: Notification of Major Holdings
26th Nov 20242:15 pmRNSTR1: Notification of Major Holdings
25th Nov 20242:38 pmRNSTR1: Notification of Major Holdings
25th Nov 20242:15 pmRNSTR1: Notification of Major Holdings
7th Nov 20248:29 amRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
17th Oct 20247:00 amRNSQ3 Trading Update
4th Oct 20241:22 pmRNSDirector/PDMR Shareholding
1st Oct 20247:01 amRNSBlock Listing Six Monthly Return
1st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 20247:00 amRNSChair and Board Committee Changes
23rd Sep 20247:00 amRNSTR1: Notification of Major Holdings
19th Sep 202410:27 amRNSTR1: Notification of Major Holdings
18th Sep 20241:39 pmRNSDirector/PDMR Shareholding
17th Sep 20247:01 amRNSDirector/PDMR Shareholding
17th Sep 20247:00 amRNSDirector/PDMR Shareholding
13th Sep 20243:54 pmRNSTR1: Notification of Major Holdings
10th Sep 202412:00 pmRNSDirector/PDMR Shareholding
9th Sep 20247:00 amRNSStrategic progress and trading momentum continues
2nd Sep 20247:00 amRNSTotal Voting Rights
19th Aug 20247:00 amRNSTR1: Notification of Major Holdings
14th Aug 20247:00 amRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSInterim Results
1st Aug 20247:00 amRNSTotal Voting Rights
29th Jul 20247:00 amRNSBetMGM H1 Update
22nd Jul 20247:00 amRNSAppointment of Chief Executive Officer
9th Jul 20249:00 amRNSEntain publishes ESG report
8th Jul 20247:00 amRNSBoard Appointment
1st Jul 20247:30 amRNSBlock Listing Application – Free Share Plan
1st Jul 20247:00 amRNSChange of registered office
1st Jul 20247:00 amRNSTotal Voting Rights
20th Jun 20249:46 amRNSTR1: Notification of Major Holdings
6th Jun 20247:01 amRNSDirector/PDMR Shareholding
6th Jun 20247:00 amRNSTR1: Notification of Major Holdings
5th Jun 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.